Justice Department Launches UnitedHealth Group Antitrust Investigation

In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! The U.S. Justice Department is investigating UnitedHealth Group (NYSE: UNH) due to antitrust concerns. During the past two years, the insurance giant has completed a slew of acquisitions […]

Hospice Investors to Watch in 2024

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Only three hospice deals took place in the third […]

JVs a Major Growth Engine for Hospices in 2024

Moving into 2024, more hospices see joint ventures or similar partnerships to be a major growth engine. Nearly half of 143 respondents to Hospice News’ 2024 Outlook Survey, conducted with Homecare Homebase, said that joint ventures and partnerships were the growth tactics they planned to pursue the most this year. More than 62% of the […]

[UPDATED] Brookdale Sells 20% Stake in Hospice, Home Health JV with HCA

For $27 million, HCA Healthcare (NYSE: HCA) has acquired Brookdale Senior Living’s (NYSE: BKD) 20% stake in a hospice, home health and therapy joint venture between the two companies. HCA now owns 100% of the business. The joint venture formed in 2021 when the senior housing operator sold an 80% stake in its health care […]

How PE Firms Are Adjusting Hospice Exit Strategies in a Shifting Market

Private equity firms typically turn around and sell an asset within three to five years post-acquisition. However, some may slow that cycle down in today’s economic environment. The presence of private equity firms in the hospice arena has expanded exponentially during the past several years. But this year, deal volume slowed across the board. While […]

2023’s Most Impactful Hospice Deals

A rich mix of hospice merger and acquisition (M&A) activity at the end of 2023 is fueling trends into next year. Hospice M&A activity has diverged from the frenzied pace set in recent years. The hospice space in the last five years has seen record-breaking multiples, a prevalence of private equity-backed platform transactions and large-scale […]

Principles Underlying Optum’s Home-Based Care Deals

Optum Health’s home-based care acquisitions are designed to support an overarching goal of expanding value-based care and diversifying clinical capabilities. The UnitedHealth Group (NYSE: UNH) subsidiary in June penned an agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. This followed its $5.4 billion acquisition of LHC Group, […]

How Quality, Utilization Will Shape Hospice M&A in 2024

Investment trends in the hospice industry have meandered in recent years, impacting providers’ approaches to growth in 2024. The mix of hospice buyers has become more diverse during the past five years to include more private equity investors, large health and hospital systems and home health companies, along with payers. These trends will have lasting […]

Home-Based Care a Continuing Growth Engine for UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is leveraging its subsidiary Optum to drive growth in value-based care arrangements, with building out its home-based care capabilities as a high priority. This drive is evidenced by Optum’s pending acquisition of Amedisys (NASDAQ: AMED) and its purchase of home health and hospice provider LHC Group, which closed in February. By […]

Lawmakers Ask DOJ, FTC to Examine Optum’s Amedisys Transaction

Sen. Elizabeth Warren (D-Massachusetts) and Rep. Pramila Jayapal (D-Washington) have called on the U.S. Justice Department (DOJ) and the Federal Trade Commission (FTC) to “scrutinize” the pending acquisition of Amedisys (NASDAQ: AMED) by Optum Health. Optum, a subsidiary of UnitedHealth Group (NYSE: UHN), in June penned its agreement to acquire Amedisys in an all-cash transaction […]